Cited by 411Cannabis and Cannabinoid ResearchAlzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement

Open access

Esposito, Giuseppe, Scuderi, Caterina, Valenza, Marta, Togna, Giuseppina Ines, Latina, Valentina, De Filippis, Daniele, Cipriano, Mariateresa, Carratù, Maria Rosaria, Iuvone, Teresa, Steardo, Luca·2011·PLoS ONE

DOI 10.1371/journal.pone.0028668PMC PMC3230631

Open this paper in CoChat — free account Open PDF

Abstract

Peroxisome proliferator-activated receptor-γ (PPARγ) has been reported to be involved in the etiology of pathological features of Alzheimer's disease (AD). Cannabidiol (CBD), a Cannabis derivative devoid of psychomimetic effects, has attracted much attention because of its promising neuroprotective properties in rat AD models, even though the mechanism responsible for such actions remains unknown. This study was aimed at exploring whether CBD effects could be subordinate to its activity at PPARγ, which has been recently indicated as its putative binding site. CBD actions on β-amyloid-induced neurotoxicity in rat AD models, either in presence or absence of PPAR antagonists were investigated. Results showed that the blockade of PPARγ was able to significantly blunt CBD effects on reactive gliosis and subsequently on neuronal damage. Moreover, due to its interaction at PPARγ, CBD was observed to stimulate hippocampal neurogenesis. All these findings report the inescapable role of this receptor in mediating CBD actions, here reported.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0028668

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Mechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580
GSK-3α regulates production of Alzheimer's disease amyloid-β peptides
Phiel, C. J., Wilson, C., Lee, V. M. ‐., & Klein, P. S. (2003) · Nature · doi:10.1038/nature01640 · Cited by 1,211
Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network
Bookout, A. L., Jeong, Y., Downes, M., Yu, R. T., Evans, R. M., & Mangelsdorf, D. J. (2006) · Cell · doi:10.1016/j.cell.2006.06.049 · Cited by 1,015
Adult neurogenesis: from precursors to network and physiology
Abrous, D. N., Koehl, M., & Le Moal, M. (2005) · Physiological Reviews · doi:10.1152/physrev.00055.2003 · Cited by 971
Cannabidiol and (−)Δ 9 -tetrahydrocannabinol are neuroprotective antioxidants
Hampson, A. J., Grimaldi, M., Axelrod, J., & Wink, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8268 · Cited by 850
Integration of metabolism and inflammation by lipid-activated nuclear receptors
Bensinger, S. J., & Tontonoz, P. (2008) · Nature · doi:10.1038/nature07202 · Cited by 827
Cannabinoids go nuclear: evidence for activation of peroxisome proliferator‐activated receptors
O’Sullivan, S. E. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707423 · Cited by 509
Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages
Rosa, M. D., Radomski, M. W., Carnuccio, R., & Moncada, S. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91583-e · Cited by 454
Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists
Kapadia, R. (2008) · Frontiers in Bioscience · doi:10.2741/2802 · Cited by 433
Neuroprotective effect of cannabidiol, a non‐psychoactive component from Cannabis sativa, on β‐amyloid‐induced toxicity in PC12 cells
Iuvone, T., Esposito, G., Esposito, R., Santamaria, R., Di Rosa, M., & Izzo, A. A. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2003.02327.x · Cited by 361
Self-citation

Flagged first, then by citations

Show all 41 references

Sorted by citations

Items 301–400 of 411

The development and therapeutic potential of classical and next-generation cannabinoid ligands
Muñoz-Canales, V., Benhamú, B., Martín‐Fontecha, M., Vázquez‐Villa, H., & Ortega‐Gutiérrez, S. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.108022 · Cited by 8
Investigation on the neuroprotective effect of a cannabidiol-enriched non-psychotropic Cannabis sativa L. extract in an in vitro model of excitotoxicity
Borgonetti, V., Biagi, M., Galeotti, N., Manetti, F., & Governa, P. (2022) · Fitoterapia · doi:10.1016/j.fitote.2022.105315 · Cited by 8
Feline cognitive dysfunction as a model for Alzheimer’s disease in the research of CBD as a potential treatment—a narrative review
Zadik-Weiss, L., Ritter, S., Hermush, V., Asher, N., Avital, A., & Or, R. (2020) · Journal of Cannabis Research · doi:10.1186/s42238-020-00054-w · Cited by 12
Therapeutic Molecular Insights into the Active Engagement of Cannabinoids in the Therapy of Parkinson’s Disease: A Novel and Futuristic Approach
Jain, V., Behl, T., Sehgal, A., Singh, S., Sharma, N., Makeen, H. A., Albratty, M., Meraya, A. M., & Najmi, A. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00619-y · Cited by 8
Cannabidiol and Neuroprotection: Evidence from Preclinical Studies
Schröder, N., da Silva, V. K., Hallak, J. E. C., Zuardi, A. W., & Crippa, J. A. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00095-8 · Cited by 7
Evaluation of the Efficacy of a Full-Spectrum Low-THC Cannabis Plant Extract Using In Vitro Models of Inflammation and Excitotoxicity
Ross-Munro, E., Isikgel, E., & Fleiss, B. (2024) · Biomolecules · doi:10.3390/biom14111434 · Cited by 9
Cannabidiol improves learning and memory deficits and alleviates anxiety in 12-month-old SAMP8 mice
Goodland, M. N., Banerjee, S., Niehoff, M. L., Young, B. J., Macarthur, H., Butler, A. A., Morley, J. E., & Farr, S. A. (2025) · PLoS ONE · doi:10.1371/journal.pone.0296586 · Cited by 10
Effects of the Acute and Chronic Administration of Cannabidiol on Cognition in Humans and Animals: A Systematic Review
Bomfim, A. J. D. L., Zuze, S. M. F., Fabrício, D. D. M., Pessoa, R. M. D. P., Crippa, J. A. S., & Chagas, M. H. N. (2023) · Cannabis and Cannabinoid Research · doi:10.1089/can.2023.0086 · Cited by 7
The Neuroprotective Properties, Functions, and Roles of Cannabis sativa in Selected Diseases Related to the Nervous System
Mahdi, O., Baharuldin, M. T. H., Nor, N. H. M., Chiroma, S. M., Jagadeesan, S., & Moklas, M. A. M. (2021) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524921666210127110028 · Cited by 6
Synthetic and Natural Derivatives of Cannabidiol
Morales, P., & Jagerovic, N. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-61663-2_2 · Cited by 7
Cannabidiol mitigates alcohol dependence and withdrawal with neuroprotective effects in the basolateral amygdala and striatum
Dirik, S., Doyle, M. R., Wood, C. P., Campo, P., Martinez, A. R., Fannon, M. J., Balaguer, M. G., Seely, S., Montoya, B. A., Cook, G. M. R., et al. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02164-6 · Cited by 7
Therapeutic Potential for Cannabidiol on Alzheimer’s Disease-Related Neuroinflammation: A Systematic Review and Meta-Analysis
Wu, S., Rajiah, T., & Ali, A. B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262411963 · Cited by 9
FDA-approved cannabidiol [Epidiolex®] alleviates Gulf War Illness-linked cognitive and mood dysfunction, hyperalgesia, neuroinflammatory signaling, and declined neurogenesis
Kodali, M., Madhu, L. N., Kolla, V. S. V., Attaluri, S., Huard, C., Somayaji, Y., Shuai, B., Jordan, C., Rao, X., Shetty, S., et al. (2024) · Military Medical Research · doi:10.1186/s40779-024-00563-2 · Cited by 9
A Phase I Randomized, Double-blind, Placebo-controlled Study on Efficacy and Safety Profile of a Sublingually Administered Cannabidiol /Delta 9-tetrahydrocannabidiol (10: 1) Regimen in Diabetes Type 2 Patients
Afshar, S., Khalili, S., Amin, G., & Abbasinazari, M. (2023) · Iranian journal of pharmaceutical research · doi:10.5812/ijpr-132647 · Cited by 6
Cannabidiol attenuates prepulse inhibition disruption by facilitating TRPV1 and 5-HT1A receptor-mediated neurotransmission
Pedrazzi, J. F. C., Silva-Amaral, D., Issy, A. C., Gomes, F. V., Crippa, J. A., Guimarães, F. S., & Bel, E. D. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173879 · Cited by 7
A review on the syntheses of Dronabinol and Epidiolex as classical cannabinoids with various biological activities including those against SARS-COV2
Tadayon, N., & Ramazani, A. (2021) · Journal of the Iranian Chemical Society · doi:10.1007/s13738-021-02212-0 · Cited by 6
Multi-Omic Analysis Reveals Disruption of Cholesterol Homeostasis by Cannabidiol in Human Cell LinesPreprint
Guard, S. E., Chapnick, D. A., Poss, Z. C., Ebmeier, C. C., Jacobsen, J. R., Nemkov, T. G., Ball, K. A., Webb, K. J., Simpson, H. L., Coleman, S. J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.03.130864 · Cited by 6
The Influence of an Acute Administration of Cannabidiol or Rivastigmine, Alone and in Combination, on Scopolamine-Provoked Memory Impairment in the Passive Avoidance Test in Mice
Kruk-Słomka, M., Słomka, T., & Biała, G. (2024) · Pharmaceuticals · doi:10.3390/ph17060809 · Cited by 5
A journey through cannabidiol in Parkinson’s disease
Del-Bel, E., Barros, N., de Moraes, R. A. P. D. S., de Mattos, B. A., Alves-Fernandes, T. A., de Abreu, L. B., Nascimento, G. C., Escobar-Espinal, D. M., Pedrazzi, J. F. C., Jacob, G. A., et al. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.04.015 · Cited by 4
The effects of cannabidiol and its main metabolites on human neural stem cells
Latham, L. E., Gu, Q., Liu, S., Wang, C., & Liu, F. (2025) · Experimental Biology and Medicine · doi:10.3389/ebm.2025.10608 · Cited by 5
Neurological Improvement with Medical Cannabis in a Progressive Supranuclear Palsy Patient: A Case Report
Hounie, A. G., & Vasques, M. A. A. (2019) · Medical Cannabis and Cannabinoids · doi:10.1159/000503864 · Cited by 5
Traditional and Innovative Anti-seizure Medications Targeting Key Physiopathological Mechanisms: Focus on Neurodevelopment and Neurodegeneration
Sciaccaluga, M., Ruffolo, G., Palma, E., & Costa, C. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230504160948 · Cited by 7
Acetylcholinesterase Inhibitory Activity of Standardized Cannabinoids-rich Fractions
Suttithumsatid, W., Kara, J., Lomlim, L., & Nualsri, C. (2023) · Pharmaceutical and Biomedical Research · doi:10.32598/pbr.9.3.1054.1 · Cited by 5
Sex-Specific Cannabidiol- and Iloperidone-Induced Neuronal Activity Changes in an In Vitro MAM Model System of Schizophrenia
Thériault, R.-K., St‐Denis, M., Hewitt, T., Khokhar, J. Y., Lalonde, J., & Perreault, M. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115511 · Cited by 5
Behavioural effects of oral cannabidiol (CBD) treatment in the superoxide dismutase 1 G93 A (SOD1G93 A) mouse model of amyotrophic lateral sclerosis
Ghimire, S., Kreilaus, F., Porto, R. R., Anderson, L. L., Yerbury, J. J., Arnold, J. C., & Karl, T. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06785-z · Cited by 4
Decoding the Therapeutic Potential of Cannabis and Cannabinoids in Neurological Disorders
Kale, M. B., Umare, M. D., Wankhede, N. L., Deshmukh, R., Abbot, V., Anwer, M. K., Taksande, B. G., Upaganlawar, A. B., Umekar, M. J., Ramniwas, S., et al. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128318194240918113954 · Cited by 4
Ketogenic Diet and PPARgamma
Simeone, T. A. (2016) · doi:10.1093/med/9780190497996.003.0020 · Cited by 4
Cannabinerol and NSC-34 Transcriptomic Analysis: Is the Dose Who Makes Neuronal Differentiation?
Valeri, A., Chiricosta, L., Gugliandolo, A., Pollastro, F., Salamone, S., Zingale, V. D., Silvestro, S., & Mazzon, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147541 · Cited by 4
Endocannabinoids and Alzheimer’s disease
Fagan, S. G., & Campbell, V. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-417041-4.00002-3 · Cited by 4
Enfermagem: um estudo da fisiopatologia do Alzheimer e os seus tratamentos alternativos com células-tronco e cannabis
Silva, G. R. D. M., Reis, G. K., Lopes, K. A., Rebelo, L. S., de Alencar, S. R. F., Serra, V. D. S., & Lopes, G. D. S. (2020) · Research Society and Development · doi:10.33448/rsd-v9i11.10094 · Cited by 4
Synthetic Cannabinoids in Dementia
Amanullah, S. L., Shivakumar, K., Hassan, S., Canfield, A., & Cole, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00100-9 · Cited by 3
Cannabidiol and Multiple Sclerosis
Mecha, M., Feliú, A., Carrillo-Salinas, F. J., & Guaza, C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00108-3 · Cited by 4
Synergistic neuroprotection of chitosan-cannabidiol nanoparticles in a rat model of Alzheimer's disease: Amelioration of cognitive deficits and neuroinflammation
Naserramezani, Z., Palizvan, M. R., Ganji, A., Ghazavi, A., & Mosayebi, G. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251379420 · Cited by 3
Effects of Chronic 100 mg/kg Cannabidiol Treatment in Male Double Transgenic APPSwe/PS1∆E9 Mice
Watt, G., Olaya, J. C., Muench, G. W., Garner, B., & Karl, T. (2026) · Pharmaceuticals · doi:10.3390/ph19030374 · Cited by 3
Cannabidiol and Alzheimer Disease: A Comprehensive Review and In Silico Insights Into Molecular Interactions
Mello-Hortega, J. V., Oliveira, C. S.-D., Araújo, V. E. S. D., Alle, L. F., Tureck, L. V., & de Souza, R. L. R. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70229 · Cited by 9
Exploring the therapeutic potential of cannabidiol in soft tissue wound healing: Delivery strategies and anti-inflammatory pathways
Dubņika, A., Jurgelāne, I., Grava, A., Tornacı, S., Porfiryeva, N. N., Solovyov, D., Saha, N., Saha, N., Kelle, E., Loča, D., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.10.001 · Cited by 5
The Endocannabinoid System in Local and Systemic Inflammation
Kelly, M. E. M., Lehmann, C., & Zhou, J. (2017) · Colloquium Series on Integrated Systems Physiology From Molecule to Function · doi:10.4199/c00151ed1v01y201702isp074 · Cited by 4
The Development of Cannabidiol as a Psychiatric Therapeutic: A Review of Its Antipsychotic Efficacy and Possible Underlying Pharmacodynamic Mechanisms
Jalali, S. (2013) · International Neuropsychiatric Disease Journal · doi:10.9734/indj/2013/6192 · Cited by 3
Overview of Medicinal Cannabis
O’Brien, K., & Blair, P. (2021) · Springer eBooks · doi:10.1007/978-3-030-78559-8_4 · Cited by 3
Cannabidiol dose dependently reduces alcohol intake in mice via a non‐5‐HT1A receptor mechanism: Exploration of other potential receptor targets
Badolato, C. J., Lynch, E. A., Arnold, J. C., McGregor, I. S., & Bowen, M. T. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70070 · Cited by 3
Cannabidiol and other non-psychotropic cannabinoids from Cannabis sativa as therapeutics for microglial-mediated neuroinflammation and neurodegeneration
Fowler, D. K., Savage, T. M., & Mackie, D. I. (2026) · Journal of Cannabis Research · doi:10.1186/s42238-026-00445-5 · Cited by 3
Peroxisome Proliferator Activated Receptors and Cannabinoids
Muñóz, E., Pollastro, F., Taglialatela‐Scafati, O., & Appendino, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00080-6 · Cited by 2
Medicinal Herbs and Nutritional Supplements for Dementia Therapy: Potential Targets and Clinical Evidence
Dorman, G. S., Flores, I., Gutiérrez, C., Castaño, R. F., Aldecoa, M., & Kim, L. M. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210809121230 · Cited by 3
O uso do Canabidiol no tratamento de doenças neurológicas selecionadas: uma revisão sistemática
Schlesner, G. M., Malagri, C. A. N., Gevehr, D. L., & Thaines, A. H. (2022) · Concilium · doi:10.53660/clm-388-506 · Cited by 2
The moderating effect of physical activity on the relationship between neutrophil count and depressive symptoms
Guo, Z., Xie, Z., Wang, P., Li, S., Xin, X., & Wang, X. (2024) · Scientific Reports · doi:10.1038/s41598-024-63432-x · Cited by 2
Repeated Administration of a Full-Spectrum Cannabidiol Product, Not a Cannabidiol Isolate, Reverses the Lipopolysaccharide-Induced Depressive-Like Behavior and Hypolocomotion in a Rat Model of Low-Grade Subchronic Inflammation
Júnior, L. R. D. N., da Silva, T. V., da Silva, L. M., de Andrade, F. M., da Silva, A. R., Meneguzzo, V., Ramos, S. D. S., Lopes, C. M., Saturnino, A. B., Inserra, A., et al. (2024) · Cannabis and Cannabinoid Research · doi:10.1089/can.2024.0086 · Cited by 2
Effects of cannabidiol (CBD) treatment on age-related cognitive decline in C57 mice
Agha, B. M., Monteith, M., Earl, J., Ganske, K., Kaloa, T., McDonald, K. J., Nixon, A. G., Panjwani, M., Robinson, D., Rusnak, V., et al. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1567650 · Cited by 3
Large-Scale Profiling of Coding and Long Noncoding Transcriptomes in the Hippocampus of Mice Acutely Exposed to Vaporized CBD or THC
Choi, M., Kim, J., Park, C., Chang, S. H., Kim, H., Jin, Y. B., & Lee, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157106 · Cited by 2
CANNABIDIOL AS A NOVEL THERAPY FOR ALZHEIMER’S DISEASE
Viana, T. R. X. (2023) · Health and Society · doi:10.51249/hs.v3i04.1466 · Cited by 1
Effects of Cannabidiol in Adolescent and Young Adult Depressive and Anxiety Disorders: A Systematic Review of Clinical and Preclinical Research
Denson, R. K., Brooks, J. M., Pinna, G., & Crane, N. A. (2023) · Adolescent Psychiatry · doi:10.2174/0122106766233339230919143924 · Cited by 1
Trace amine-associated receptor 1 (TAAR1) activation reduced mania-relevant hyperexploration and risky decision-making in dopamine transporter knockdown mice
Munir, T. Y., Roberts, B. Z., & Young, J. W. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251364394 · Cited by 1
Cannabidiol and Parkinson's disease: Investigating receptor interactions and their therapeutic implications
Okrah, E. A., Allan, C. Y., Doblin, M. S., & Annesley, S. J. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108943 · Cited by 2
The effects of chronic cannabidiol administration on brain pathology and behavioral deficits found in the tau P301s-line PS19 mouse model of Alzheimer's disease
Nixon, A. G., Hong, N. S., Agha, B. M., Ham, J. R., Monteith, M., Kaloa, T., Kyriazopolus, A., Nielsen, M., Robertson, D. R., Golubov, A., et al. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261421654 · Cited by 1
Cannabidiol and pBDNF Cotreatment Attenuates Pathological Symptoms and Improves Cognition in 3 month-Old 5XFAD Mice
Chaulagain, B., Gothwal, A., Mahanta, A. K., Jarajapu, Y. P. R., & Singh, J. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c01009 · Cited by 1
Cannabidiol and epilepsy: therapeutic, mechanistic and clinical significance
Gupta, N., Maan, P., Shrivastava, J., & Ansari, M. H. R. (2026) · Seizure · doi:10.1016/j.seizure.2026.06.014 · Cited by 2
Pharmacological Targeting of Peroxisome Proliferator-activated Receptors for Prevention of Radiation-induced Cognitive Decline
Ghanekar, S., Raj, J. A. T., Thiruselvan, G. K., Kulkarni, R., Soni, M., Chatterjee, A., Patro, I., & Goda, J. S. (2026) · Annals of Neurosciences · doi:10.1177/09727531261452006 · Cited by 1
Immunotoxicology of Drugs of Abuse
Kaplan, B. L. F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64180-6 · Cited by 1
Cannabinoids
Harry, G. J. (2022) · Advances in neurotoxicology · doi:10.1016/bs.ant.2022.06.001 · Cited by 2
Cannabidiol and Indole-3-carbinol Reduce Intracellular Lipid Droplet Accumulation in HepaRG, A Human Liver Cell Line, as well as in Human Adipocytes
Senthilkumar, S., Solan, M. E., Fernández-Luna, M. T., & Lavado, R. (2023) · The Natural Products Journal · doi:10.2174/2210315513666230526100544 · Cited by 1
Impact of cannabidiol on brain glucose metabolism of C57Bl /6 male mice previously exposed to cocaine
Spelta, L. E. W., Real, C. C., Bruno, V., Buchpiguel, C. A., Garcia, R. C. T., Torres, L. H., Faria, D. D. P., & Marcourakis, T. (2024) · Journal of Neuroscience Research · doi:10.1002/jnr.25327 · Cited by 1
Phytocannabinoids: a new frontier in Alzheimer’s disease management
Rao, J. S. (2024) · Academia Biology · doi:10.20935/acadbiol7344 · Cited by 1
Cannabidiol as a treatment for patients who are clinically at high risk of developing psychosis: learnings from the CANTOP-RCT
Bhattacharyya, S., Davies, C., Carter, B., McGuire, P. K., Brammer, M. J., Fusar‐Poli, P., Broome, M. R., Watson, S., Pérez, J., & Yung, A. R. (2024) · Efficacy and Mechanism Evaluation · doi:10.3310/ynfh9826 · Cited by 1
L’usage du cannabidiol dans le sport : une bonne idée ?
Gamelin, F.-X., Berthoin, S., Cuvelier, G., Mendes, A., Anthierens, A., & Heyman, E. (2021) · Science & Sports · doi:10.1016/j.scispo.2021.03.003 · Cited by 2
Dementia: Alzheimer’s Disease
O’Brien, K., & Blair, P. (2021) · Springer eBooks · doi:10.1007/978-3-030-78559-8_9 · Cited by 1
Revisão integrativa: verificação da eficácia / efetividade da Cannabis medicinal e dos derivados canabinoides na Doença de Alzheimer
de Moraes, P. Z., Fukushima, A. R., & Nicoletti, M. A. (2022) · Revista Fitos · doi:10.32712/2446-4775.2022.1255 · Cited by 1
Cannabidiol in traumatic brain injury
Palazzo, E., Iannotta, M., Belardo, C., Infantino, R., Ricciardi, F., Boccella, S., Guida, F., Luongo, L., & Maione, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823347-4.00032-4 · Cited by 1
Medicinal Cannabis for Alzheimer's Disease
Steiner, G. Z., Coles, M., Jaye, K. M., Metri, N., Butt, A. S., Christofides, K., McPartland, J., Al-Modhefer, Z., Karamacoska, D., Russo, E. B., et al. (2023) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-6684-5652-1.ch001 · Cited by 1
Membrane Lipid Switches: How Membrane Lipid Structure Influences Protein–Lipid InteractionsPreprint
Torres, M., Rosselló, C. A., Fernández‐García, P., Lladó, V., & Escribá, P. V. (2020) · doi:10.32545/encyclopedia202004.0017.v2
Cannabidiol treatment of proliferating 3T3-L1 pre-adipocytes affects mature cell size and expression of acyltransferases involved in lipid droplet synthesisPreprint
Caldari‐Torres, C., Huang, M., Kasprovic, D. A., & Xu, Y. (2023) · Research Square · doi:10.21203/rs.3.rs-2689027/v1 · Cited by 1
Evaluation of the efficacy of a full-spectrum medicinal cannabis plant extract with less than 0.3% Δ9-tetrahydrocannabinol in in vitro models of inflammation and excitotoxicityPreprint
Ross-Munro, E., Isikgel, E., & Fleiss, B. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.10.575133 · Cited by 1
The innate defensive behaviour and unconditioned fear-induced antinociception evoked by NMDA receptor activation in the medial hypothalamus are modulated by the intradiencephalic treatment with cannabidiol: the role of CB1 cannabinoid receptor
Khan, A. U. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2019.tde-29042019-162811
Ketogenic Diet and PPARγ
Simeone, T. A. (2022) · doi:10.1093/med/9780197501207.003.0023
Cannabidiol (CBD) drives sex-dependent impairments in omission, but has no effect on reinforcer devaluation
Morehouse, C., Maddox, C., van der Merwe, R. K., McLaughlin, R., Scott, J. R., Ghanem, M. M., Ramsson, E. S., & Howard, C. D. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114023
Canabidiol em modelo pré-clínico de dor neuropática: uma avaliação dos aspectos sensoriais, emocionais e inflamatórios relacionados com a modulação da sensibilidade dolorosa
Cardoso, G. K. R. D. S. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.59.2022.tde-01092022-134636
Caracterização da neuroinvasividade do SARS-CoV-2 e dos efeitos neuroprotetores do canabidiol em um modelo in vitro utilizando o sistema celular SH-SY5Y
dos Santos, I. P. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2022.tde-09092022-091724
Cannabidiolic acid (CBDA), features and profiles: Anti-hyperalgesic effects
Linher‐Melville, K., Mechoulam, R., & Singh, G. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90036-2.00005-3
Evaluation of mental maturity and right-left orientation and correlations with gait and balance in children with Autism Spectrum disorder: preliminary study
Mendes, J. D. O. H., Cordeiro, L. B., Santos, G. N., Duarte, N. D. A. C., Grecco, L. A. C., Moraes, P. M., & Oliveira, C. S. (2023) · Contribuciones a las Ciencias Sociales · doi:10.55905/revconv.16n.9-120
Modulation of neuroinflammation by natural molecules
Maurya, S. K., & Mishra, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23763-8.00008-7
The Moderating Effect of Physical Activity on the Relationship Between Neutrophils and Depression: A Cross-sectional Analysis Based on the NHANES DatabasePreprint
Guo, Z., Zhenwen, X. I. E., Peng, W. A. N. G., Li, S., Xin, X., & Wang, X. (2024) · Research Square · doi:10.21203/rs.3.rs-3850398/v1
Mecanismo de ação do canabidiol em processos neurodegenerativos associados ao envelhecimento: uma revisão integrativa
Gavioli, A., Cadeu, A. B., Laurentino, G. C., & Ortiz, S. R. M. (2024) · Journal Archives of Health · doi:10.46919/archv5n1-007 · Cited by 2
Effects of Cannabis Exposure on Adolescent Health and Development: A Narrative Review
Li, R. L., & Tao, F. (2024) · Current Drug Research Reviews · doi:10.2174/0125899775273727231224185028
Immunotoxicology of Drugs of Abuse
Kaplan, B. L. F. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00051-6
Cbd-Enriched Hemp (Cannabis Sativa L.) Extract Attenuates Cognitive Impairments and Glial Activations in Rats Exposed to Chronic StressPreprint
Kamsrijai, U., Charoensup, R., Hawiset, T., Thaweethee-Sukjai, B., Praman, S., & Jaidee, W. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4816951
Cannabinoid Neurotransmission: Neurotoxicity or Neuroprotection
Kumar, U. (2024) · Royal Society of Chemistry eBooks · doi:10.1039/9781839165795-00290
Cannabidiol como um potencial tratamento anti-inflamatório na infecção respiratória (revisão integrativa)
Marinho, A. G. C., de Souza, I. A., Cadena, P. G., Lima‐Filho, J. V., Alves, A. J., da Silva, M. S., & da Silva, V. A. (2024) · Cuadernos de Educación y Desarrollo · doi:10.55905/cuadv16n6-183
Biological and therapeutic aspects of combination of radiotherapy with selected immune modulators
Gottwald, A., Tang, Y., Fietkau, R., Gaipl, U. S., & Jost, T. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14064-8.00027-8
A Self-Emulsifying Nanococktail of Pomegranate and Cannabidiol Reduces Cognitive Decline in Mice
Shoseyov, O., Palatnik, A., Dadon‐Freiberg, M., Dagan, O., & Shaltiel‐Karyo, R. (2025) · Nutrition and Dietary Supplements · doi:10.2147/nds.s484222
Cannabidiol/tetrahydrocannabinol-enrich extract decreases neuroinflammation and improves locomotor outcome following spinal cord injury
Core, J. D., Jure, I., Sofrás, F. M. S., Pietranera, L., Ronchetti, S., Roig, P., Desimone, M. F., Nicola, A. F. D., & Labombarda, F. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.03.055
Cannabidiol improves short-term memory in a Streptozotocin-induced animal model of Alzheimer’s diseasePreprint
Pereira, G. C., Silva, V. A., Soares‐Silva, B., Taliano, L. O., Carvalhinho-Lopes, P. S., Custódio‐Silva, A. C., Silva, E., Lambertucci, R. H., Abílio, V. C., dos Santos, J. R., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-7197783/v1
Cannabis use is associated with alterations in NLRP3 inflammasome related gene expression in monocyte-derived macrophages from people living with HIV
Walter, K. C., Avalos, B., Ford, M. K., Laird, A. E., Boustani, A., Spencer, M. R., Shu, L., Chaillon, A., Crescini, M., Cookson, D., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1634203 · Cited by 3
FIGURES 45. Axinyssa djiferi spec. nov. 4 in A new species of Axinyssa Lendenfeld, 1897 (Porifera, Demospongiae, Halichondrida) from the Senegalese coast
Boury‐Esnault, N., Marschal, C., Probst, J.-M. K., & Barnathan, G. (2002) · INFM-OAR (INFN Catania) · doi:10.5281/zenodo.155630
Cannabidiol–Ion Channel Interactions Represent a Promising Preventive and Therapeutic Strategy in Hepatocellular Carcinoma
Chávez-López, M. D. G., Ávalos‐Fuentes, A., Cruz-Manzo, E. D. C., Aguirre-Arriaga, P. A., Florán, B., Pérez‐Carreón, J. I., Bañuelos, C., & Camacho, J. (2026) · Pathophysiology · doi:10.3390/pathophysiology33010008
Cannabinoids and cognition in Parkinson’s disease: Insights from animal models and emerging clinical evidence
Kitchigina, V. F., & Shubina, L. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.03.023 · Cited by 1
Assessment of Cannabidiol Supplements Use in Small Animals Practice in Portugal
Santos, M. I., & Lourenço, A. L. (2026) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/jpn.70059
Molecular thermodynamic aspects of dissipative structures in oncology, inflammatory and degenerative processes of Central Nervous System diseases
Vallée, A. (2017) · theses.fr (ABES) · doi:10.70675/e07edff7z4f56z4165z8ee2z475c4aafb600
Cannabidiol (CBD) Promotes Post-TBI Astrocyte Viability and Decreases Injury-Induced Glial Stress Responses Across Zebra Finch Song Control NucleiPreprint
Marshall, D. A., Litwa, K., & Soderstrom, K. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.13.717820
Cannabidiol Limits Early Aβ‐Induced Glial Activation and Preserves Synaptic Integrity in Primary Mouse Hippocampal Neuron–Glia Cultures
Salgado, K. D. C. B., de Albuquerque, A. L. S., Pedrosa, T. C. F., Cota, A. A. B., Talvani, A., Oliveira, L. A. M., & Nogueira, K. D. O. P. C. (2026) · European Journal of Neuroscience · doi:10.1111/ejn.70588
The neuroimmune-glutamate hypothesis of addiction
Gipson, C. D., White, A. M., Richie, D. L., McNealy, K. R., Stoops, W. W., & Ornelas, L. C. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106859
Chronic CBD treatment differentially modulates neurobehavioral outcomes and endocannabinoid signaling in an aged HIV-1 Tat transgenic mouse model
Yadav-Samudrala, B. J., Johnson, M. L., Ale, A., Jiang, K. X., Lee, W. W. Y., Nguyen, A., Ho, D., Acquah, E. B., Orsucci, I. C., Sawaqed, L. E., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0353267
Modified self-assembled cannabidiol–albumin nanoparticles for enhanced brain delivery and neuroprotection in an Alzheimer’s model
Lamichhane, S., Shakhakarmi, K., Kim, H., Seo, J., Lee, S., & Lee, S. (2026) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-026-00820-7

Authors: Esposito, G., Scuderi, C., Valenza, M., Togna, G. I., Latina, V., De Filippis, D., Cipriano, M., Carratù, M. R., Iuvone, T., & Steardo, L.
Affiliations: Sapienza University of Rome (IT)
University of Bari Aldo Moro (IT)
University of Naples Federico II (IT)
Corresponding author: Steardo, Luca
ORCID: Esposito, Giuseppe
Scuderi, Caterina
Valenza, Marta
Latina, Valentina
Cipriano, Mariateresa
Carratù, Maria Rosaria
Steardo, Luca
Venue: PLoS ONE
Publisher: Public Library of Science (PLoS)
Published: 2011-12-05
Volume: 6
Issue: 12
Pages: e28668
ISSN: 1932-6203 (ISSN-L)
DOI: 10.1371/journal.pone.0028668
PMC: PMC3230631
OpenAlex: W2107076749
Cited by: 410
References: 41
Citations by year: 2026: 23 · 2025: 24 · 2024: 53 · 2023: 41 · 2022: 49 · 2021: 48 · 2020: 45 · 2019: 22 · 2018: 18 · 2017: 26 · 2016: 16 · 2015: 13 · 2014: 8 · 2013: 13 · 2012: 10
FWCI: 7.26
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0/ (unspecified)
Locations: PLoS ONE (publishedVersion, cc-by)
Europe PMC (PubMed Central) (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
Funders: Ministero dell’Istruzione, dell’Università e della Ricerca
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: cannabidiol, PPARγ, Alzheimer's disease, amyloid-beta, neuroinflammation, hippocampal neurogenesis, reactive gliosis, neuroprotection, PPARγ antagonist, neurotoxicity
MeSH terms: Animals, Astrocytes, Binding Sites, Brain, Cannabidiol, Hippocampus, Inflammation, Male, Neurons, Nitric Oxide, Protein Binding, Time Factors, Amyloid beta-Peptides, Rats, Sprague-Dawley, Protein Structure, Tertiary, PPAR gamma, Rats, Neurogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks